Browse Careers
Browse Investors

Press Releases

Please note that the information in each of the following press releases is only current as of the date of the release.  C. R. Bard, Inc. undertakes no obligation to update the information in the press releases to reflect new information, the occurrence of future events or circumstances, or otherwise.

April 30, 2012
Bard Names Christopher S. Holland Senior Vice President and Chief Financial Officer
April 24, 2012
Bard Announces First Quarter Results
April 18, 2012
Bard Declares Quarterly Dividend
April 17, 2012
Bard to Host Earnings Conference Call on April 24, 2012
January 31, 2012
Bard Announces Fourth Quarter Results
January 24, 2012
Bard to Host Earnings Conference Call on January 31, 2012
December 20, 2011
Bard Acquires Lutonix, Inc.
December 14, 2011
Bard Declares Quarterly Dividend
November 3, 2011
Bard to Host December 2011 Investor Conference
October 25, 2011
Bard Announces Agreement to Acquire Medivance, Inc.
October 25, 2011
Bard Announces Third Quarter Results
October 13, 2011
Bard to Host Earnings Conference Call on October 25, 2011
October 12, 2011
Bard Declares Quarterly Dividend
August 1, 2011
Bard Announces Retirement of Todd C. Schermerhorn, Senior Vice President and Chief Financial Officer
July 21, 2011
Bard Announces Second Quarter Results
July 14, 2011
Bard to Host Earnings Conference Call on July 21, 2011
June 8, 2011
Bard Increases Quarterly Dividend
April 21, 2011
Bard Announces First Quarter Results
April 20, 2011
Bard Declares Quarterly Dividend
April 14, 2011
Bard to Host Earnings Conference Call on April 21, 2011
February 10, 2011
Bard Names Todd W. Garner Vice President, Investor Relations
January 31, 2011
Bard Announces Fourth Quarter Results Revenue Up 6 Percent as Reported, 7 Percent Excluding Foreign Exchange
January 24, 2011
Bard to Host Earnings Conference Call on January 31, 2011
December 14, 2010
Bard Provides Financial Guidance for 2011
December 8, 2010
Bard Declares Quarterly Dividend
November 4, 2010
Bard to Host December 2010 Investor Conference
October 21, 2010
Bard Announces Third Quarter Results Diluted EPS of $1.34, $1.43 on Adjusted Basis
October 14, 2010
Bard to Host Earnings Conference Call on October 21, 2010
October 13, 2010
Bard Declares Quarterly Dividend
July 22, 2010
Bard Announces Second Quarter Results
July 15, 2010
Bard to Host Earnings Conference Call on July 22, 2010
July 6, 2010
Bard Closes Transaction to Acquire SenoRx, Inc.
June 9, 2010
Bard Announces $500 Million Share Repurchase Authorization
June 9, 2010
Bard Increases Quarterly Dividend
May 5, 2010
Bard Announces Agreement to Acquire SenoRx, Inc.
April 22, 2010
Bard Announces First Quarter Results
April 21, 2010
Bard Declares Quarterly Dividend
April 15, 2010
Bard to Host Earnings Conference Call on April 22, 2010
February 10, 2010
NEJM Publishes Trial Results Demonstrating Bard FLAIR(R) Endovascular Stent Graft is Superior to Balloon Angioplasty for Failing Dialysis Grafts
January 28, 2010
Bard Announces Fourth Quarter Results
January 21, 2010
Bard to Host Earnings Conference Call on January 28, 2010
December 9, 2009
Bard Declares Quarterly Dividend
November 16, 2009
Bard to Host December 2009 Investor Conference
October 21, 2009
Bard Announces Third Quarter Results
October 14, 2009
Bard Declares Quarterly Dividend
October 14, 2009
Bard to Host Earnings Conference Call on October 21, 2009
September 29, 2009
Court Rules in Favor of Bard in Class Action Lawsuit
August 14, 2009
10b5-1(c) Trading Plan Announcement – Website Distribution Only
July 22, 2009
Bard Announces Second Quarter Results
July 15, 2009
Bard to Host Earnings Conference Call on July 22, 2009
June 10, 2009
Bard Increases Quarterly Dividend
April 22, 2009
Bard Announces First Quarter Results
April 15, 2009
Bard Declares Quarterly Dividend
April 15, 2009
Bard Announces $500 Million Share Repurchase Authorization
April 15, 2009
Bard to Host Earnings Conference Call on April 22, 2009
April 13, 2009
Bard Promotes Jim C. Beasley to Group Vice President
February 17, 2009
Bard Receives FDA Approval for the LifeStent(R) Vascular Stent
January 29, 2009
Bard Announces Fourth Quarter Results Revenue up 9 Percent as Reported, 12 Percent Excluding Foreign Exchange
January 22, 2009
Bard to Host Earnings Conference Call on January 29, 2009
December 10, 2008
Bard Declares Quarterly Dividend
December 8, 2008
Bard Receives FDA Approval for the E*Luminexx(TM) Vascular Stent
December 2, 2008
Bard to Host December 2008 Investor Conference
December 2, 2008
10b5-1(c) Trading Plan Announcement – Website Distribution Only
October 29, 2008
Bard Receives FDA Approval for the Flair(TM) Endovascular Stent Graft
October 22, 2008
Bard Announces Third Quarter Results
October 15, 2008
Bard to Host Earnings Conference Call on October 22, 2008
October 8, 2008
Bard Declares Quarterly Dividend
August 20, 2008
JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia
July 30, 2008
Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates
July 23, 2008
Bard Announces Second Quarter Results
July 16, 2008
Bard to Host Earnings Conference Call on July 23, 2008
June 25, 2008
Bard Promotes Sharon M. Alterio to Group Vice President
June 11, 2008
Bard Increases Quarterly Dividend
June 6, 2008
Bard Closes Transaction to Acquire Specialized Health Products International, Inc.
April 23, 2008
Bard Announces First Quarter Results
April 16, 2008
Bard Declares Quarterly Dividend
April 15, 2008
Bard to Host Earnings Conference Call on April 23, 2008
March 10, 2008
Bard Signs Agreement to Acquire Specialized Health Products International, Inc.
January 31, 2008
Bard Announces Fourth Quarter Results
January 18, 2008
Bard to Host Earnings Conference Call on January 31, 2008
January 14, 2008
Bard Closes Transaction to Acquire LifeStent(R) from Edwards Lifesciences
December 17, 2007
Bard to License Hernia Product and Technology from Genzyme Corporation
December 12, 2007
Bard Declares Quarterly Dividend
December 12, 2007
Bard Announces Patent Infringement Verdict against W. L. Gore & Associates
December 7, 2007
Bard Signs Agreement to Acquire LifeStent(R) from Edwards Lifesciences
December 5, 2007
Bard to Host December 2007 Investor Conference
November 8, 2007
Bard Receives Clearance to Market Agento(TM) IC Silver-Coated Endotracheal Tube
October 23, 2007
Bard Announces Third Quarter Results
October 16, 2007
Bard to Host Earnings Conference Call on October 23, 2007
October 10, 2007
Bard Announces $500 Million Share Repurchase Authorization
October 10, 2007
Bard Declares Quarterly Dividend
July 24, 2007
Bard Announces Second Quarter Results
July 17, 2007
Bard to Host Earnings Conference Call on July 24, 2007
June 21, 2007
Bard Promotes John A. DeFord, Ph.D., to Senior Vice President, Science, Technology and Clinical Affairs
June 13, 2007
Bard Increases Quarterly Dividend
April 24, 2007
Bard Announces First Quarter Results
April 18, 2007
Bard Declares Quarterly Dividend
April 17, 2007
Bard to Host Earnings Conference Call on April 24, 2007
April 12, 2007
C. R. Bard Marks Centennial in 2007
March 12, 2007
Bard Appoints James M. Howard II as Vice President, Regulatory Sciences
February 20, 2007
Bard Promotes Stephen J. Long to Vice President, General Counsel and Secretary
January 25, 2007
Bard Announces Fourth Quarter Results
January 18, 2007
Bard to Host Earnings Conference Call on January 25, 2007
December 13, 2006
Bard Declares Quarterly Dividend
December 4, 2006
Bard to Host December 2006 Investor Conference
October 18, 2006
Bard Announces Third Quarter Results
October 11, 2006
Bard Declares Quarterly Dividend
October 11, 2006
Bard to Host Earnings Conference Call on October 18, 2006
July 19, 2006
Bard Announces Second Quarter Results; Revenue up 11 Percent as Reported, 12 Percent Excluding Foreign Exchange
July 12, 2006
Bard to Host Earnings Conference Call on July 19, 2006
June 14, 2006
Bard Increases Quarterly Dividend
April 21, 2006
10b5-1(c) Trading Plan Announcement - Website Distribution Only
April 19, 2006
Bard Declares Quarterly Dividend
April 18, 2006
Bard Announces First Quarter Results; Revenue up 9 Percent as Reported, 11 Percent in Constant Currency
April 11, 2006
Bard to Host Earnings Conference Call on April 18, 2006
April 10, 2006
Bard Completes Acquisition of Venetec International, Inc.
March 3, 2006
Bard Concludes Enrollment in Infection Control Endotracheal Tube Trial
March 1, 2006
Bard Signs Agreement to Acquire Venetec International, Inc.
January 25, 2006
Bard Announces Fourth Quarter Results; Earnings Per Share up 15 Percent
January 18, 2006
Bard to Host Earnings Conference Call on January 25, 2006
January 18, 2006
Bard Acquires New Stent Technology
January 13, 2006
Bard Announces Recall of Composix(R) Kugel(R) Mesh X-Large Patch
December 16, 2005
Bard Announces $500 Million Share Repurchase Authorization
December 14, 2005
Bard Declares Quarterly Dividend
December 1, 2005
Bard to Host December 2005 Investor Conference
October 18, 2005
Bard Announces Third Quarter Results
October 12, 2005
Bard Declares Quarterly Dividend
October 11, 2005
Bard to Host Earnings Conference Call on October 18, 2005
August 16, 2005
Tommy G. Thompson Elected to Bard's Board of Directors
July 19, 2005
Bard Announces Second Quarter Results
July 12, 2005
Bard to Host Earnings Conference Call on July 19, 2005
June 8, 2005
Bard Increases Quarterly Dividend
April 20, 2005
Bard Declares Quarterly Dividend
April 20, 2005
John H. Weiland Elected to Bard's Board of Directors; Former Chairman, President and CEO William H. Longfield Retires from Board
April 19, 2005
Bard Announces First Quarter Results
April 12, 2005
Bard to Host Earnings Conference Call on April 19, 2005
March 16, 2005
Bard Updates First Quarter Guidance
March 11, 2005
Bard's CEO to Speak at the SG Cowen & Co. 25th Annual Health Care Conference
January 26, 2005
C. R. Bard earnings release issued prematurely
January 26, 2005
Bard Exceeds Fourth Quarter Earnings Expectations; Earnings Per Share at 65 Cents
January 19, 2005
Bard to Host Earnings Conference Call on January 26, 2005
January 12, 2005
Bard Acquires Certain Assets of Genyx Medical
December 10, 2004
Bard Declares Quarterly Dividend
December 1, 2004
Bard to Host December 2004 Investor Conference
October 19, 2004
Bard Reports Third Quarter Results; Net Sales up 17 Percent, 15 Percent on Constant Currency Basis
October 15, 2004
Bard Names Judith A. Reinsdorf Vice President, General Counsel and Corporate Secretary
October 13, 2004
Bard Declares Quarterly Dividend
October 12, 2004
Bard to Host Earnings Conference Call on October 19, 2004
October 1, 2004
Bard Closes Sale of Endoscopic Assets
August 18, 2004
Bard to Divest Endoscopic Assets
July 20, 2004
Bard Reports Second Quarter Results; Net Sales up 15 Percent on Constant Currency Basis
July 14, 2004
Gail K. Naughton, Ph.D., Elected to Bard's Board of Directors
July 14, 2004
Bard Increases Quarterly Dividend
July 13, 2004
Bard to Host Earnings Conference Call on July 20, 2004
July 1, 2004
Bard Acquires Hernia Repair Fixation System
June 1, 2004
June is National Hernia Awareness Month; Innovative, Minimally Invasive Technique Speeds Procedure and Recovery Time
April 21, 2004
Bard Declares Quarterly Dividend and Announces Two-For-One Stock Split
April 20, 2004
Bard Reports First Quarter Results; Net Sales Up 13 Percent On Constant Currency Basis
April 13, 2004
Bard to Host Earnings Conference Call on April 20, 2004
March 9, 2004
Bard Updates First Quarter Guidance
January 28, 2004
Bard Reports Fourth Quarter Results; Sales up 11 Percent on Constant Currency Basis
January 21, 2004
Bard to Host Earnings Conference Call on January 28, 2004
January 20, 2004
Bard Names New VP of Science & Technology
December 10, 2003
Bard Declares Quarterly Dividend
December 2, 2003
Bard to Host December 2003 Investor Conference
October 27, 2003
Bard Launches Enhanced Corporate Web Site; Valuable Tool and Information Resource for Investors, Customers, & Patients
October 15, 2003
Bard Reports Third-Quarter Results Net Sales up 12%, Earnings Per Share at 98 Cents
October 9, 2003
Theodore E. Martin Elected To Bard's Board Of Directors
October 8, 2003
Bard to Host Earnings Conference Call on October 15, 2003
October 8, 2003
Bard Declares Quarterly Dividend
August 12, 2003
Bard Receives Clearance to Market Removable Vena Cava Filter
August 8, 2003
Bard Succession Plan Complete
July 24, 2003
Bard Acquires Vacuum-Assisted Biopsy Device
July 16, 2003
Bard Reports Second Quarter Results; Earnings up 13%, Sales Up 12%
July 9, 2003
Bard to Host Earnings Conference Call on July 16, 2003
July 9, 2003
Bard Increases Quarterly Dividend
July 8, 2003
Bard Receives Clearance to Market HemoSplit Dialysis Catheter
June 23, 2003
Bard Announces Introduction of Fluent Constant Flow Pump in Europe
June 16, 2003
Bard Acquires Source Tech Medical
May 2, 2003
ADVISORY/Live Webcast Showcasing Bard's Innovative, Minimally-Invasive Procedure To Treat Chronic Heartburn Sufferers
April 29, 2003
Bard Names Group Vice Presidents
April 16, 2003
Bard Declares Quarterly Dividend
April 15, 2003
Bard Exceeds First Quarter Expectations; Earnings Per Share at 89 Cents
April 9, 2003
Bard Names Scott T. Lowry Vice President And Treasurer
April 7, 2003
Bard Names Eric J. Shick Vice President- Investor Relations
April 4, 2003
Bard to Host Spring 2003 Investor Conference
February 28, 2003
Bard Names Todd C. Schermerhorn Senior Vice President and Chief Financial Officer
February 19, 2003
Bard Files Suit Under Pourchez Patent
February 13, 2003
Multimedia Available: Bard Board Approves Succession Plan: Timothy M. Ring to Succeed William H. Longfield as Chairman and CEO
February 13, 2003
Bard Board Approves Succession Plan: Timothy M. Ring to Succeed William H. Longfield as Chairman and CEO; John H. Weiland to Become President and COO
January 28, 2003
Bard Exceeds Fourth Quarter Expectations - Earnings Per Share at $.89
January 24, 2003
Bard Announces Agreement to Acquire Genyx Medical
January 21, 2003
Bard to Host Earnings Conference Call on January 28, 2003
January 3, 2003
Bard Announces New Technology To Revolutionize Umbilical Hernia Repair
December 13, 2002
Bard Provides Financial Guidance for 2003; Company Reaffirms Fourth Quarter 2002 Guidance
December 12, 2002
Bard Announces 5 Million Share Purchase Authorization
December 11, 2002
Bard Declares Quarterly Dividend
December 10, 2002
Bard to Host Guidance Conference Call On December 13, 2002
October 21, 2002
Recent Media Report On Bard Succession Plan Erroneous
October 16, 2002
Bard Exceeds Third Quarter Earnings Expectations - EPS of $0.85 Per Share Before Non-Recurring Items
October 9, 2002
Bard to Host Earnings Conference Call On October 16, 2002
October 9, 2002
Bard Declares Quarterly Dividend
September 11, 2002
Bard's CEO To Speak At Bear Stearns' 15th Annual Healthcare Conference
August 20, 2002
Bard Announces Issuance Of ePTFE Vascular Patent
July 18, 2002
Bard Taps Washington Veteran
July 17, 2002
Consistent Sales Growth Drives Bard's Second Quarter EPS
July 10, 2002
Bard Increases Quarterly Dividend
July 10, 2002
Bard To Host Earnings Conference Call
June 3, 2002
June is National Hernia Month
April 19, 2002
Herbert L. Henkel Elected To Bard's Board Of Directors
April 17, 2002
Bard Reports First Quarter Results in Line with Guidance
April 17, 2002
Bard Declares Quarterly Dividend
April 12, 2002
Bard Will Host Spring 2002 Investor Conference
April 8, 2002
Bard To Host Earnings Conference Call On April 16, 2002
February 8, 2002
Bard Provides Financial Guidance For 2002
February 6, 2002
Bard and Tyco Terminate Merger Agreement
January 29, 2002
Bard Reports Fourth Quarter Results
January 23, 2002
Bard Evaluates Tyco Announcement
December 12, 2001
Bard Declares Quarterly Dividend
December 10, 2001
Bard's Endocinch™ Device For Chronic Heartburn Receives New Medicare Reimbursement Code
November 15, 2001
10-Q Filing Disclosures
October 17, 2001
Bard Reports Third Quarter Results
October 10, 2001
Bard Declares Quarterly Dividend
August 7, 2001
Bard Shareholders approve merger with Tyco
July 17, 2001
Bard Reports Second Quarter Results
July 11, 2001
Bard Declares Quarterly Dividend
June 28, 2001
Bard receives approval for Advanced Ablation Catheter

bard-pubs

Primary Media Relations Contact

Scott Lowry
Vice President and Treasurer
C. R. Bard, Inc.
730 Central Avenue
Murray Hill, NJ 07974

Tel: 908-277-8365